EPCAM and prostate carcinoma: The values derived with the EpCAM-based bead system are comparable to those CTC counts which have been isolated from patients with prostate cancer (mean 124 ± 400) using the FDA-approved EpCAM mAb-based CELLSEARCH® system [30,31,32,33].